
Sapphiros
Consumer diagnostics company offering rapid, at-home tests for infectious diseases and personalized wellness insights.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $30.0m | Series B | |
Total Funding | 000k |
Related Content
Sapphiros is a global AI Bio computational biology company that provides solutions to help people make informed decisions. They offer real-time, definitive results through their products, ranging from rapid home tests to advanced laboratory testing services. Sapphiros is a leader in genetic and COVID-19 testing, and are also developing a device that will provide the highest performing diagnostics in the palm of your hand. Additionally, they are creating a convenient patch for rapid, point of care diagnosis. They are also working on proprietary molecular detection technologies that will enable near patient and at-home testing for infectious diseases and generic indications. Sapphiros is backed by a team of experienced healthcare executives and a leading global investment firm, KKR. They are committed to investing in growth stage companies that have the vision and passion to bring transformative new diagnostic technologies to the world.
Tech stack
Investments by Sapphiros
Edit